Provaxus

Provaxus is a private biotechnology company developing and commercializing microbiome-based health products, with an initial focus on gastrointestinal inflammation and digestive health. The company licensed an engineered Lactobacillus acidophilus strain from North Carolina State University and brought it to market under the CodonRX brand. Its lead commercial product uses the patented NCK2025 strain, a modified probiotic designed to reduce gut inflammation and support digestive balance. Provaxus appears to operate at the intersection of biotech and consumer health, translating university-derived microbiome science into broadly accessible products. Publicly available information indicates the company is active, privately held, and led by founder Kevin White.